- Conditions
- Aspirin Exacerbated Respiratory Disease (AERD)
- Interventions
- Ifetroban, Oral Capsule, Placebo, Oral Capsule
- Drug
- Lead sponsor
- Cumberland Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 19 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 3
- States / cities
- San Diego, California • Overland Park, Kansas • West Nyack, New York
Source: ClinicalTrials.gov public record
Updated May 14, 2017 · Synced May 22, 2026, 5:13 AM EDT